Drawing for PYVOT

USPTO serial 90663691

PYVOT

Reviewed by CopyMark Law Group

Status 654
Filing date
Status date
Registration date
—
Examiner
YARD, JOHN S
Law office
TMO LAW OFFICE 115

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PYVOT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Marc A. Lieberstein

Marc A. Lieberstein KILPATRICK TOWNSEND & STOCKTON LLPMAILSTOP: IP DOCKETING - 221100 PEACHTREE STREET, SUITE 2800ATLANTA, GA 30309-4528

Goods and services

ClassDescriptionStatusFirst use
010Therapeutic weighted vests, sweatshirts and scarves to provide proprioceptive input to the body; compression garments, namely, compression leggings, compression pants, compression shirts, compression vests, compression sleevesACTIVE—
025Athletic apparel, namely, shirts, pants, leggings, jackets, hats, sweatshirts, vests and sports brasACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 26, 2026RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Nov 9, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Nov 8, 2025RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
May 7, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
May 7, 2025RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Nov 6, 2024RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Dec 24, 2023RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jun 22, 2023RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jun 21, 2023RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jun 21, 2023RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Dec 7, 2022RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
May 23, 2022GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
May 23, 2022GNSLLETTER OF SUSPENSION E-MAILED—
May 23, 2022CNSLSUSPENSION LETTER WRITTEN—
Apr 20, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 19, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 19, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 18, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 18, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 18, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 16, 2021DOCKASSIGNED TO EXAMINER—
Jul 30, 2021MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 29, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 26, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance